WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
World Liver Day
19th April
Visit the World Liver Day website > Here
Raising awareness about the vital role of the liver
#WorldLiverDay #StepUpForLiverHealth
BASL ANNUAL MEETING
8th-11th October 2024
BASL Annual Meeting 2024 - Tuesday 8th - Friday 11th October, including BLTG Transplant Meeting & BLNA Meeting. The venue is Harrogate Convention Centre, Harrogate. Abstract Submission Open - closes 9am 7th June 2024 - read more on the Events page here. Submit an Abstract here. A programme and registration will be available soon.
BASL ANNUAL MEETING
REGISTER HERE
BLNA
MEETING
REGISTER HERE
BLTG
MEETING
REGISTER HERE
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
PSC Support Research Grants
Read morePSC Support is inviting funding applications for:
• Project Award £50,000 - worldwide (closing date 01 May 2024)
• Seed Funding Awards £15,000 to generate pilot or proof-of-concept data - worldwide (closing date 01 May 2024)
• Research Training Fellowship (£300,000) - UK-only (closing date 01 June 2024)
More information: https://pscsupport.org.uk/apply-for-funding
New technology could spot and treat liver cirrhosis complications sooner
Read moreA new study is recruiting now. The research will look at the CirrohCare system for managing and treating decompensated cirrhosis. The system uses smart devices to let people check their condition at home. Doctors can see the data in real time with algorithms helping to spot potential problems early. A preliminary study found positive responses from patients and a reduction in hospital treatment.
Find out more
British Liver Trust
Putting a spotlight on liver health: an update from the UK Liver Alliance
Read moreJoin this webinar on Tuesday, 9th April at 5pm for an exclusive update from the UK Liver Alliance, a coalition of more than 30 organisations who are committed to improving liver health.
From pioneering efforts in early detection within primary care to initiatives aimed at reducing variation in hospital care and driving policy change, this event promises insights that are both informative and inspiring. Speakers include Professor Phil Newsome, Dr Rebecca Jones, Dr Andrew Yeoman and Dr Helen Jarvis.
The SHiNE-UK Study (Surveillance and Care for HCC: A National Evaluation) is now live
Read moreThe SHiNE-UK study (Surveillance and Care for HCC: A National Evaluation) is now live.
Further information and all study docs are available on REDCap dashboard here; www.REDCap.link/SHiNE-UKdashboard.
Do you want to help to research an increasingly important clinical question in hepatology? Do you want to get involved in a large national collaborative project with PubMed-cited collaborative authorship?
SHiNE-UK (Surveillance and care for Hepatocellular carcInoma: a National Evaluation) is a multi-centre project aiming to understand HCC surveillance adherence and outcomes, routes to diagnosis and treatment utilisation across the UK.
SHiNE-UK is a trainee-led multicentre retrospective study that is led by the Trainee Collaborative for Research and Improvement for Hepatology (ToRcH-UK) and hosted by Manchester University NHS Foundation Trust. I
This project comprises of 3 threads:
• Survey of the current provision of HCC surveillance and care (site leads only)
• To assess HCC surveillance adherence and outcomes for patients active in surveillance (all sites – projected 20-60 cases per site)
• To assess routes to diagnosis and first line treatment utilisation for incident HCC (network HPB MDT sites only – projected 30-90 cases per site)
All clinicians, including specialist nurses and allied health professionals are encouraged to take part. Local project teams will gather retrospective data between February and July 2024. All data will be submitted anonymously on REDCap. Each site will have a site lead (registrar) with a supervising gastroenterology/hepatology consultant. The study can be registered via your local Audit Department and will not require R&D approval.
If you would like to take part, please access the SHiNE-UK study dashboard which provides the protocol and supporting materials www.REDCap.link/SHiNE-UKdashboard.
Key Dates
27-Nov-2023 - Site registration opens
19-Feb-2024 - REDCap data collection opens
30-Apr-2024 - Site registration closes
31-Jul-2024 - REDCap data collection closes
Download SHiNE-UK Promotional Poster v1.0 04-Feb-24.pdf
If you have any questions, please contact us via committee@torchuk.org. We look forward to working with you on this exciting project!
Best wishes
SHiNE-UK Project Management Group
X @SHiNEUK_study
Clinical Research Fellow - Hepatology - NDM Experimental Medicine, John Radcliffe Hospital, Oxford.
Read moreAbout the Role
We are seeking to appoint a highly motivated, clinically qualified candidate (with an interest in hepatology, hepatobiliary surgery or oncology) to join our established, multi-disciplinary team, to undertake a clinical fellowship in liver cancer early detection. The post is full time, for 3 years, and the successful applicant would be expected to register for a DPhil (PhD). Your fees for the DPhil will be paid.
You will play an active role in the execution of clinical studies within DeLIVER (https://deliver.cancer.ox.ac.uk/), a CRUK funded program that seeks to detect hepatocellular liver cancer (HCC) early.
You will be responsible for supporting the DeLIVER team in acquiring liver tissue by i) performing fine needle aspirations/liver biopsy, and ii) by liaising with the interventional radiologists and hepatobiliary surgeons. This program would involve the evaluation of biomarkers (immune and/or genetic) in blood, HCC, and the back-ground liver, that will support early cancer detection and enhance our understanding of pathways in the liver that lead to HCC transformation.
Informal queries may be addressed to Prof Ellie Barnes, ellie.barnes@ndm.ox.ac.uk .
A link to the full application can be found here: Job Details (corehr.com)
Please note the tight deadlines – the application closes on 15th March, with interviews expected on the 25th or 26th March 2024
Events
Registration Closed - Meeting Full
Date: 22nd April
Registration: 09:30am to 10:00am
Meeting Time: 10:00am to 5:00pm
Location: Lloyd Suite, Edgbaston Park Hotel, 53 Edgbaston Park Road, Birmingham B15 2RS
Hepatocellular carcinoma is a major cause of cancer mortality in the UK. NICE guidelines recommend that people with cirrhosis should receive HCC surveillance, defined as an ultrasound scan of the liver every six months. The goal of surveillance is to detect HCC early when it is easier to treat. However, the delivery and implementation of surveillance in the UK (as in many other countries) is suboptimal and has been for many years. Indeed, only a minority of eligible patients receive adequate surveillance, and most people who develop HCC are diagnosed at advanced stages.
Our meeting will showcase new ideas and developments for improving HCC surveillance in the UK. We will highlight key initiatives that are currently underway in the UK to increase early HCC detection. We will discuss the latest thinking on personalised surveillance and consider what relevance and application this has to HCC. We will also look at what new surveillance tests are on the horizon and how these innovations are likely to alter the surveillance landscape. Our meeting will feature a wide range of renowned speakers, researchers and opinion leaders in this field.
The organisers; Tim Cross, Hamish Innes and Tom Bird have put together a great line up.
Please keep this date free and make the journey to Birmingham if you can. You will not be disappointed.
Download HCC monothematic program_v13.03.24.pdf
The event is Free to attend and a £25 deposit will be taken at the time of booking, which is refunded when you attend the event.
Terms and Conditions apply - Cancellations received on or after the 8th April will not be accepted and no refunds will be provided.
1 week to go!
BASL Xtra is an online educational conference.
Three afternoons of multi-professional liver learning on Tuesday 23rd, Wednesday 24th and Thursday 25th of April from 13:00-16:30 each day.
BASL X-tra will have something for everyone - multi-professional, topic-focused education delivered online with attractive rates.
Catch up will be available and for up to 28 days later.
23rd April - Session 1: PBC and X-tra hepatic manifestations
24th April - Session 2: Optimising health in people with stable cirrhosis
25th April - Session 3: Liver Grand-rounds: Complex and controversial cases
View a draft programme here > Download BASL Xtra programme_16.04.pdf
REGISTER by Clicking > HERE
Registration from just £20 for members:
From £20 for nurses, pharmacists, AHPs, students and scientists
From £50 for trainees
From £75 for consultants
Awarded 9 CPD credits
Contact admin@basl.org.uk for any queries.
Thank you to our sponsors:
Join the ILCA Single Topic Workshop, an insightful and unmissable event to delve into systemic therapies, exploring topics such as patient experiences, first-line therapy selection for HCC, second-line therapy options, and groundbreaking advancements in treating BTC. Curious to learn more?
Join ILCA on 26-27 April 2024 in Madrid, Spain.
Link to register: https://ilcalive.org/registration-2/
BASL members are offered a 10% discount - the code to enter upon registration will be included in the February members newsletter or members can contact admin@basl.org.uk .
Join us 08 – 10 May 2024 for a hybrid event accommodating an international audience!
Live at the Radisson Blu Hotel, Stansted Airport, Essex, UK
And Virtual
REGISTRATION NOW OPEN
AMMF’s 2024 cholangiocarcinoma (CCA) conference will bring together an expert faculty to deliver an engaging hybrid event exploring the European and international aspects of CCA.
To register for this event in person, or virtually, and for venue and accommodation information, visit the AMMF website by clicking > Here.
To view the 3-day conference programme click > Here .
Call for Abstracts – Now Open
Deadline - 15 March 2024 - visit the AMMF website for full details, click > Here.
The annual AMMF CCA conference facilitates and encourages the sharing of information amongst interested medics in the UK, Europe and internationally. It provides an opportunity to find out about improvements in treatments, new and ongoing clinical trials, updates on research and encourages collaboration between researchers and medics.
For full information on AMMF’s CCA Conference 2024 and how to register in person or virtual, visit the AMMF website by clicking > Here.
AMMF’s conference will be a CPD accredited event.
08/05/24
REGISTER NOW - through Zoom by clicking HERE
Are you a budding Hepatologist? Or a new consultant wanting to know more about specific areas of Hepatology? Do you want to improve you hepatology knowledge to permit Hepatology curriculum sign off? Have you got questions but not had the opportunity to ask them?
If yes then please join us for the BASL Virtual School of Hepatology Webinar Series 2024/5. The BASL Virtual School of Hepatology Sessions offer an excellent platform for trainees and consultants interested in hepatology, with talks delivered by UK Hepatologists, followed by a Q&A session.
Following the success of the series in 2021, 2022 & 2023 we are running a series of 6 bi-monthly webinars through 2024 and 2025 on a Wednesday evening.
We are delighted to announce our first session and speaker for May:
Session 1: Outpatient management of cirrhosis
Speaker: Dr Dina Mansour
Date: Wednesday 8th May 2024
UK Time: 19:00 – 20:00
FREE to attend for BASL Members.
REGISTER NOW - through Zoom by clicking HERE
Not a member of BASL, then why not join by clicking > HERE
Remember to read the BASL Events Data Protection Disclaimer below before registering Download BASL Events Data Protection Disclaimer_2022.pdf
Please contact kim@basl.org.uk should you have any questions.
Thank you to our supporter:
And our Partner:
This webinar series is supported by Dr Falk and Astra Zeneca. They have had no influence or input into the programme, agenda or content of the meeting.
Quick Links
